| Log in

IFCI Venture Capital Invests $4.6M In Marck Biosciences

25 August, 2008

IFCI Venture Capital (IVCL)  has invested $4.6 million (Rs 20 crore) in Ahemadabad-based Marck Biosciences Ltd. The company is involved in manufacturing of sterile dosage products and with this round of funding plans to open up a new plant. Marck Biosciences is planning to set up a new plant along its existing facility in Kheda, which would require an additional capital of Rs 60 crore. The additional capital would be sourced through further borrowings and internal accruals. The company had revenues of Rs 56 crore last year, a quarter of which came from exports.

 

From the new facility, Marck plans to manufacture formulations and injectables in glass vials, sterile ointments, mono-dose ophthalmics and lens cleaning solutions for global markets. The new facility, in which Marck has already invested Rs 140 crore, is slated to open in 2010-11. Marck has a presence in 55 countries across Latin America, South-East Asia and Africa and plans to expand into 15 more countries now. Some of the clients of Marck are Sun Pharma, Zydus Cadilla and Torrent Pharma.

  

IVCL is the venture capital arm of IFCI Ltd. Some of the other companies in IVCL portfolio are Biotech Consortium India, Anik Industries and Speck Systems. IVCL recently announced the launch of three funds whose corpus total at Rs 1,000 crore. While one of them is a private equity fund with mandate to invest in automotive component industry, other two are VC funds, one is general and other to invest in cleantech companies.

 


Leave Your Comment
IFCI VC To Part-Exit In Marck Biosciences IPO

IFCI VC To Part-Exit In Marck Biosciences IPO

Pallavi S 7 years ago
IFCI Venture Capital is selling over half of the shares it owns in Ahmedabad...
Tata Capital Healthcare Fund invests in Marck Biosciences; IFCI part-exits

Tata Capital Healthcare Fund invests in Marck Biosciences; IFCI part-exits

Madhav A Chanchani 5 years ago
A private equity fund, managed by Tata Capital and focused on healthcare &...
HBM Healthcare to pick stake in Amanta Healthcare; IFCI VC to exit

HBM Healthcare to pick stake in Amanta Healthcare; IFCI VC to exit

Jasleen Kaur Batra 3 years ago
Swiss investment fund HBM Healthcare Investments Ltd, which is managed by HBM...
No Comments

IFCI Venture Capital Invests $4.6M In Marck Biosciences

Powered by WordPress.com VIP